View in EDS

A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide.

Saved in:
Bibliographic Details
Title: A phase II trial evaluating the clinical and immunologic response of HLA-A2+ non-small cell lung cancer patients vaccinated with an hTERT cryptic peptide.
Authors: Kotsakis, Athanasios1,2 georgsec@med.uoc.gr, Papadimitraki, Elisavet1,2, Vetsika, Eleni Kyriaki2, Aggouraki, Despoina2, Dermitzaki, Eleftheria Kleio1, Hatzidaki, Dora1, Kentepozidis, Nikolaos3, Mavroudis, Dimitris1,2, Georgoulias, Vassilis1,2
Source: Lung Cancer (01695002). Oct2014, Vol. 86 Issue 1, p59-66. 8p.
Database: Academic Search Ultimate
Description
ISSN:01695002
DOI:10.1016/j.lungcan.2014.07.018